Goldman Sachs Group Inc Xtant Medical Holdings, Inc. Transaction History
Goldman Sachs Group Inc
- $780 Billion
- Q3 2025
A detailed history of Goldman Sachs Group Inc transactions in Xtant Medical Holdings, Inc. stock. As of the latest transaction made, Goldman Sachs Group Inc holds 21,034 shares of XTNT stock, worth $14,092. This represents 0.0% of its overall portfolio holdings.
Number of Shares
21,034Holding current value
$14,092% of portfolio
0.0%Shares
4 transactions
Others Institutions Holding XTNT
# of Institutions
32Shares Held
80.1MCall Options Held
0Put Options Held
0-
Nantahala Capital Management, LLC New Canaan, CT68.4MShares$45.8 Million1.72% of portfolio
-
Awm Investment Company, Inc. New York, NY6.59MShares$4.42 Million0.51% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.36MShares$1.58 Million0.0% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny714KShares$478,3230.0% of portfolio
-
Geode Capital Management, LLC Boston, MA492KShares$329,6050.0% of portfolio
About Xtant Medical Holdings, Inc.
- Ticker XTNT
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 108,226,000
- Market Cap $72.5M
- Description
- Xtant Medical Holdings, Inc. develops, manufactures, and markets regenerative medicine products and medical devices for orthopedic and neurological surgeons in the United States and internationally. Its biomaterial products include OsteoSponge that provides a natural scaffold for cellular in-growth and exposes bone-forming proteins to the healin...